Insider Transactions in Q2 2021 at Intellia Therapeutics, Inc. (NTLA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
553,376
-18.7%
|
$74,705,760
$135.32 P/Share
|
|
Jun 23
2021
|
Fred E Cohen |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
John F Crowley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
Jean Francois Formela Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
Jesse Goodman |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
Georgia Keresty |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 23
2021
|
Frank Verwiel |
BUY
Grant, award, or other acquisition
|
Direct |
2,094
+50.0%
|
-
|
|
Jun 14
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
170,779
-5.03%
|
$14,857,773
$87.67 P/Share
|
|
Jun 11
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
30,946
-2.03%
|
$2,630,410
$85.58 P/Share
|
|
Apr 29
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
4,513
-0.59%
|
$383,605
$85.43 P/Share
|
|
Apr 28
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
131,926
-7.53%
|
$11,213,710
$85.76 P/Share
|
|
Apr 27
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
210,230
-6.75%
|
$18,079,780
$86.29 P/Share
|
|
Apr 26
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
806
-0.07%
|
$67,704
$84.93 P/Share
|
|
Apr 13
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,937
+1.78%
|
$259,370
$10.36 P/Share
|
|
Apr 09
2021
|
Georgia Keresty |
BUY
Grant, award, or other acquisition
|
Direct |
4,955
+50.0%
|
-
|
|
Apr 05
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
800
-0.07%
|
$67,200
$84.98 P/Share
|
|
Apr 05
2021
|
Caroline Dorsa Director |
SELL
Open market or private sale
|
Direct |
7,500
-23.83%
|
$615,000
$82.28 P/Share
|
|
Apr 05
2021
|
Caroline Dorsa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+36.75%
|
$45,000
$6.4 P/Share
|
|
Apr 01
2021
|
Jose E Rivera EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
50,455
-1.57%
|
$4,137,310
$82.98 P/Share
|
|
Apr 01
2021
|
Jose E Rivera EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
97,001
+13.04%
|
$1,261,013
$13.4 P/Share
|
|
Apr 01
2021
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
38,209
-2.71%
|
$3,171,347
$83.5 P/Share
|
|
Apr 01
2021
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
71,041
+4.77%
|
$923,533
$13.99 P/Share
|